Back to Search
Start Over
Multivalent peptide and peptidomimetic ligands for the treatment of pain without toxicities and addiction.
- Source :
-
Peptides [Peptides] 2019 Jun; Vol. 116, pp. 63-67. Date of Electronic Publication: 2019 Apr 20. - Publication Year :
- 2019
-
Abstract
- The current opioid crisis has created a tragic problem in medicine and society. Pain is the most ubiquitous and costly disease in society and yet all of our "treatments" have toxicities, especially for prolonged use. However, there are several alternatives that have been discovered in the past fifteen years that have been demonstrated in animals to have none of the toxicities of current drugs. Many of the compounds are multivalent and have novel biological activity profiles. Unfortunately, none of these have been in clinical trials in humans, perhaps because they were discovered in academic laboratories. A review of these novel chemicals are given in this paper.<br /> (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Humans
Ligands
Opioid Peptides chemistry
Opioid Peptides therapeutic use
Pain pathology
Pain Management
Peptides adverse effects
Peptidomimetics adverse effects
Receptors, Opioid chemistry
Receptors, Opioid therapeutic use
Receptors, Opioid, delta chemistry
Receptors, Opioid, delta genetics
Receptors, Opioid, mu chemistry
Receptors, Opioid, mu genetics
Analgesics, Opioid therapeutic use
Pain drug therapy
Peptides therapeutic use
Peptidomimetics therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1873-5169
- Volume :
- 116
- Database :
- MEDLINE
- Journal :
- Peptides
- Publication Type :
- Academic Journal
- Accession number :
- 31014958
- Full Text :
- https://doi.org/10.1016/j.peptides.2019.02.004